What questions should I ask before plasma exchange?
A careful plasma exchange clinic should name a supervising physician, the device and replacement fluid, run baseline tests, explain monitoring and emergency transfer, and give an itemized written quote. Ask what evidence supports your specific goal: TPE is guideline-graded for specific diseases, early or mixed for Alzheimer's, ineffective for long COVID in a sham-controlled trial, and unproven for healthy aging.
Nov 17, 2026Updated Nov 18, 20268 min read

Before booking plasma exchange, ask about supervision, the device, the replacement fluid, baseline tests, monitoring, the evidence for your goal and the itemized price. Therapeutic plasma exchange (TPE) removes plasma, the liquid part of blood, and replaces it. It is established for specific diseases, graded one by one by the American Society for Apheresis, but one clinic offering it states no course has been validated for healthy aging.
What should you ask a plasma exchange clinic before booking?
Seven questions separate a careful clinic from a casual one, and each has a concrete reason behind it. If the procedure is new to you, start with how therapeutic plasma exchange works.
| Question to ask | Why it matters |
|---|---|
| Who is the named physician, and will they be present? | Standard TPE is run by a trained nurse in a hospital or infusion center |
| Which device, and how much plasma per session? | FDA clearance covers the device, and protocols differ in volume |
| Albumin or donor plasma? | Patients who avoid blood products need to say so |
| What tests come first? | Labs, medicines and veins all affect safety |
| How will I be monitored, and what is the emergency plan? | Rarer problems include low calcium and low blood pressure |
| What evidence supports my goal, and who funded it? | Evidence ranges from guideline-graded to unproven |
| What exactly does the price include? | Prices vary with testing and number of sessions |
Who should supervise plasma exchange, and which device is used?
A named physician who knows your history should oversee treatment, with a trained nurse running the machine in a setting equipped for monitoring and emergencies. The American College of Rheumatology (ACR) says TPE is typically performed in a hospital or infusion center, using a specialized machine operated by a trained nurse.
One clinic's wording shows what to ask about. Next Health says its treatment is "performed under direct physician supervision, with monitoring throughout". Ask any clinic whether a physician will be in the room or only on call.
Then ask which machine will be used. Two common TPE devices hold FDA 510(k) clearances:
- The Spectra Optia was cleared under K071079 on August 2, 2007, with the decision "Substantially Equivalent".
- The AMICUS Separator System, made by Fenwal, was cleared for therapeutic plasma exchange under K111702 on March 22, 2012.
A device clearance does not approve every use a clinic advertises. Next Health itself says TPE is "being used off-label for these types of patients".
Ask, too, how much plasma will be processed per session and how many sessions are planned, because published protocols differ. A microplastics study used one-plasma-volume procedures, while the AMBAR Alzheimer's trial used weekly conventional exchange for 6 weeks, then monthly low-volume exchange.
What replacement fluid goes back in, and does it matter?
Removed plasma is replaced with either an albumin solution or donor plasma, and the choice matters most if you avoid blood products. Ask which fluid you will receive, and why.
The ACR advises patients to tell the medical team if they avoid blood products, which matters if you object to donor plasma for religious or personal reasons. Policies differ: Reborne Longevity, for example, states "We do not use donor plasma."
What tests should happen before the first session?
Expect blood tests, a full medication review and an assessment of your veins and circulation before the first session. How thoroughly a clinic screens tells you how seriously it takes safety.
One clinic's workup is a useful example, not a standard. Reborne Longevity lists an examination of heart and circulation along with blood count, kidney and liver function, clotting, calcium and albumin, an infection screen, a review of every medicine and an assessment of veins.
The medication review has a specific purpose. The ACR notes that plasma exchange can remove some medications, including medications you receive through an IV. Bring a complete list, including supplements, and ask who will coordinate timing with your prescribing physician.
Ask whether tests will be repeated afterward. Next Health, for example, says it does "comprehensive biomarker testing before and after". Ask what a change in those numbers would and would not tell you.
What can go wrong, and what should the emergency plan be?
The side effects the ACR describes are mostly mild, such as feeling cold, nausea or tingling, with rarer problems such as low calcium and low blood pressure. A clear monitoring and emergency plan is what makes a rare serious event manageable.
The ACR says patients may feel cold, nauseated, or experience mild tingling of the lips, hands or feet during the procedure. It also lists fatigue, and rarer problems such as low calcium and low blood pressure.
Before booking, ask the clinic:
- Who checks vital signs, and how often?
- Is cardiac monitoring used?
- What emergency equipment and medicines are on hand, and who is trained to use them?
- Which hospital would receive you if needed, and how would you get there?
Does the evidence support plasma exchange for your goal?
It depends on the goal. TPE is established for specific diseases, the evidence is early or mixed for Alzheimer's disease and environmental chemicals, a controlled trial found no benefit for long COVID, and it is unproven for healthy aging. Ask the clinic to name your goal in the consent form, with the evidence behind it.
Established
ASFA's 2026 guideline has 93 fact sheets and 183 graded and categorized indications, each summarizing the evidence for a specific disease entity or medical condition. Committee members disclose ties to device makers, including Terumo BCT and Fresenius. If you have a diagnosed condition, ask the physician where it sits in this guideline.
Emerging, with funding ties
- Alzheimer's disease: the AMBAR trial randomized 347 patients with mild-to-moderate Alzheimer's, with albumin and, in some arms, IVIG replacement. Decline in daily activities was 52% smaller (P = .03), the cognitive score showed only a trend (P = .06), and there were no changes in mild-AD patients. Grifols funded the study, and several authors are Grifols employees.
- Biological age: a single-blinded trial in 42 healthy adults over 50 reported 15 epigenetic clocks showing rejuvenation compared to placebo. Two adverse events required stopping treatment, and randomization was based on entry date. Author D. Kiprov is co-founder and chief science officer of Circulate, and his affiliations include Global Apheresis Inc.
- Microplastics: a study of 114 patients and 174 procedures found lower blood levels after treatment, but at low starting levels the drop was obscured by microplastics leaching from the apheresis tubing. Most authors are affiliated with Circulate Health, and they note there is no established method for removing MP from the human body.
- PFAS ("forever chemicals"): double filtration, a different technique, showed decreases in PFAS and microplastics, though responses varied across individuals. The findings are preliminary, and the authors include Ayus Medical Group staff and an advisory-board member. For TPE itself, the main source is a single-author paper, not a trial, which says TPE may be a beneficial intervention for PFAS clearance.
The biological-age, microplastics and PFAS studies measured epigenetic clocks and blood levels. A change in these markers is not proof of a longer life or fewer diseases.
Did not work
In long COVID, 50 patients received six sessions of TPE or a sham procedure. The investigators found no differences between groups in any efficacy measure: TPE was safe but brought no discernible improvement.
Unproven
Next Health says aging is "in part, the accumulation of these toxins, stress molecules, and garbage proteins" and calls plasma exchange the most effective way to remove them. The same company also states that "no claims are made as to whether this therapy is going to cure or treat any particular disease."
What should the price include, and what are the red flags?
Ask for a written quote that itemizes consultation, baseline and follow-up labs, each session, the replacement fluid, any line placement and aftercare. Walk away from promised results, dark-plasma "proof" or a clinic that cannot name its physician.
What the price should include
Clinic prices bundle different things. MDLifespan lists its TPE 1 Protocol at $5,995 and Advanced Protocols at $15,995 to $59,995, checked November 18, 2026, and says pricing varies with diagnostic testing and number of sessions.
To compare quotes, see Northvane's dated, sourced plasma exchange prices, and the guide to what plasma exchange costs and what drives the price.
Red flags
- Promises of specific results, or of a full-body "reset".
- Dark or cloudy plasma shown as proof that toxins were removed.
- No named supervising physician, or a physician available only by phone.
- Claims that the FDA has approved TPE as a longevity treatment.
- Pressure to prepay a long series before your first session and follow-up labs.
- Vague answers about replacement fluid, monitoring or emergency transfer.
Northvane's listings of plasma exchange clinics do not rank providers; these questions apply to any of them.
Common questions
How long does a session take, and will I need a central line?
The ACR says each session lasts a few hours and describes treatment through a central line connected to the machine. A central line carries a small risk of infection and bleeding, so ask whether your veins are suitable for needle access instead, who places and removes any line, and how it will be cared for between sessions.
Is plasma exchange the same as INUSpheresis, young-plasma infusions or plasma donation?
No. TPE removes your plasma and replaces it, while INUSpheresis and other filter-based methods filter your plasma and return it; see how INUSpheresis differs from plasma exchange. Plasma donation gives your plasma to others and is not a treatment. Young-plasma infusions add donor plasma, and on February 19, 2019, the FDA warned of "no proven clinical benefit of the infusion of plasma from young donors" for conditions such as aging.
Sources14 cited
- [1]graded one by one · doi.org
- [2]Therapeutic Plasma Exchange | Reborne Longevity · rebornelongevity.com
- [3]Plasma Exchange (Plasmapheresis) | American College of Rheumatology · rheumatology.org
- [4]Therapeutic Plasma Exchange Cost | MDLifespan · mdlifespan.com
- [5]Therapeutic Plasma Exchange (TPE) · Next Health · next-health.com
- [6]510(k) Premarket Notification · accessdata.fda.gov
- [7]510(k) Premarket Notification · accessdata.fda.gov
- [8]Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? · doi.org
- [9]A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study. · doi.org
- [10]42 healthy adults over 50 · doi.org
- [11]decreases in PFAS and microplastics, though responses varied across individuals · doi.org
- [12]Role of Therapeutic Plasma Exchange in Accelerating the Clearance of Perfluoroalkyl and Polyfluoroalkyl Substances. · doi.org
- [13]Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial · doi.org
- [14]Important Information about Young Donor Plasma Infusions for Profit | FDA · fda.gov
For information, not medical advice. Suggest a correction · Editorial policy


